A Day Up For Evoke Pharma, Inc.
Fri, Aug 13, 2021 at 05:30 PM
Evoke Pharma, Inc. (EVOK:NASDAQ) soared at $1.34, representing a gain of 19.6%. On Thu, Aug 12, 2021, EVOK:NASDAQ hit a New 2-Week Intraday Low of $1.07. The stock appeared on our News Catalysts scanner on Thu, Aug 12, 2021 at 04:57 PM in the 'EARNINGS' category. From Thu, Jul 29, 2021, the stock recorded 40.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Evoke Pharma, Inc. (EVOK:NASDAQ)
Evoke Pharma Inc is a specialty pharmaceutical company which focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. It is engaged in developing an investigational metoclopramide nasal spray called Gimoti.
Top 10 Gainers:
- FLGC (FLGC:NASDAQ), 35.97%
- BIOLASE, Inc. (BIOL:NASDAQ), 25.06%
- CVD Equipment Corporation (CVV:NASDAQ), 24.63%
- IRIDEX Corporation (IRIX:NASDAQ), 20.91%
- Pilgrim's Pride Corporation (PPC:NASDAQ), 20.55%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 19.64%
- VVOS (VVOS:NASDAQ), 19.34%
- Capital Senior Living Corporation (CSU:NYSE), 18.75%
- CNVY (CNVY:NYSE), 18.28%
- ABCL (ABCL:NASDAQ), 17.77%